Conference call to be held on July 25 at 2 pm hosted by JPMorgan.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LXEO:
- Lexeo Therapeutics reports ‘positive’ results from LX2006 study
- Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
- Lexeo Therapeutics to report interim Phase 1/2 clinical data of LX2006
- Lexeo Therapeutics Welcomes New Board Member Tim Van Hauwermeiren
- Lexeo Therapeutics appoints Tim Van Hauwermeiren to board of directors